Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Microfluidic chip technology integrates basic operational units such as sample preparation, reaction, analysis, and detection, harnessing techniques from the fields of chemistry and biology into a chip of several square centimeters, automatically completing the entire analysis process.

Abbott Laboratories could have the golden touch when it comes down to detecting traumatic brain injuries (TBI). A new study shows the Abbott Park, IL-based company’s blood test, which is still under development, could help detect mild TBIs

Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool – SoToxa Mobile Test Sy

Roche has expanded the Global Access Program, originally established to increase availability of HIV diagnostics in underserved countries, to include diagnostic tests for tuberculosis, hepatitis, and human papillomavirus (HPV). Increased acc

Life science reagents and tools company Abcam announced today that it has acquired genome editing technologies firm EdiGene's live cell line and lysates portfolio.

A federal judge will limit 10x Genomics' ability to sell and market its single-cell analysis solution.

Agilent Technologies said today that it has agreed to acquire privately held life science instrumentation manufacturer BioTek Instruments for $1.17 billion in cash.

Thermo Fisher Scientific today reported a 4 percent increase in second-quarter revenues, driven by growth across its business segments.

Qiagen on Wednesday afternoon reported preliminary second quarter financial results ahead of its full Q2 earnings release next week, and said that it is adjusting its full-year financial targets downward due to lower-than-expected sales of i

PerkinElmer said after the close of the market on Monday that its total revenues in the second quarter grew 3 percent year over year but missed the consensus Wall Street estimate.

Illumina reported after the close of the market on Monday that its second quarter 2019 revenues grew 1 percent year over year.